ArticleHeliyon2024

Txnrd1 as a prognosticator for recurrence, metastasis and response to neoadjuvant chemotherapy and radiotherapy in breast cancer patients.

Raghavendra S Patwardhan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.